World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 5.922

ICV : 78.6

Abstract

A PROSPECTIVE STUDY ON THE ASSESSMENT OF PRESCRIBING PATTERN AND IMPACT OF PATIENT COUNSELLING, MEDICATION ADHERENCE AND QUALITY OF LIFE AMONG PATIENTS WITH PARKINSONISM

Dr. Malini Gopinath*, Shruthi Raju, Kripesh Kumar B. C., Sreelekshmi Vinu, Cyril Tom Mathew and
Sam Jeeva Kumar Dr. Malini Gopinath*, Shruthi Raju, Kripesh Kumar B. C., Sreelekshmi Vinu, Cyril Tom Mathew and

ABSTRACT

Background: Parkinsonism is the second most common neurodegenerative disease. Parkinson?s disease, there is a gradual loss of brain cells that make and store dopamine. Materials and Methods: A Prospective observational study was carried out for a period of 12 months and subjects were selected from the Neurology department of Cosmopolitan hospital. In the study the patients were assessed using the UPDRS, PDQL and MGL Scale and their case sheets were reviewed. Results: We analysed 104 patients. Levodopa is the mainstay as monotherapy as well as in combination with other antiparkinsonian medications. Levodopa monotherapy comprised approximately 38.46% of prescriptions in the study period, followed by Rasagiline, Amantadine and Trihexyphenidyl. Combination therapy including levodopa with either DA or other antiparkinsonian medications was 53.84% in the study period. Among the combination therapies, Levodopa + other anti- parkinsonism medications (other than DA) were the most commonly prescribed regimen. The mean of UPDRS rating score of total population has declined from 47.05+/-18.08 to 43.61+/-18.52 as compared to the initial visit at the end of study which means patient condition has improved symptomatically 7.88% by our intervention. The improvement in the medication adherence was found to be 61.33%. The improvement in quality of life was 9.19% from our intervention. Conclusion: Levodopa is the mainstay as monotherapy as well as in combination with other antiparkinsonian medications. Patient counselling had an important impact on medication adherence and quality of life of Parkinsonian Patients. Effective patient counselling and better drug compliance improved patient?s quality of life.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR